160 related articles for article (PubMed ID: 26527083)
1. Metastatic renal cell carcinoma without evidence of a renal primary.
Costantino C; Thomas GV; Ryan C; Coakley FV; Troxell ML
Int Urol Nephrol; 2016 Jan; 48(1):73-7. PubMed ID: 26527083
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α.
Tsimafeyeu I; Zart JS; Chung B
BJU Int; 2013 Jul; 112(1):32-8. PubMed ID: 23746142
[TBL] [Abstract][Full Text] [Related]
3. Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib.
Terakawa T; Miyake H; Kusuda Y; Fujisawa M
Urol Oncol; 2013 May; 31(4):493-8. PubMed ID: 21478036
[TBL] [Abstract][Full Text] [Related]
4. Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinoma.
Ayllon J; Beuselinck B; Morel A; Barrascout E; Medioni J; Scotte F; Oudard S
Cancer Invest; 2011 May; 29(4):282-5. PubMed ID: 21469976
[TBL] [Abstract][Full Text] [Related]
5. Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case report.
Messina C; Di Meglio A; Nuzzo PV; Boccardo F; Ricci F
Tumori; 2015; 101(3):e79-81. PubMed ID: 26417621
[TBL] [Abstract][Full Text] [Related]
6. Patients with metastatic renal cell carcinoma with long-term disease-free survival after treatment with sunitinib and resection of residual metastases.
Rini BI; Shaw V; Rosenberg JE; Kim ST; Chen I
Clin Genitourin Cancer; 2006 Dec; 5(3):232-4. PubMed ID: 17239278
[TBL] [Abstract][Full Text] [Related]
7. [A case report of renal cell carcinoma with bilateral adrenal metastases].
Miyamoto S; Higashi H; Okamura K; Matsuo Y; Kobayashi M; Yamanaka H
Hinyokika Kiyo; 1997 Feb; 43(2):127-30. PubMed ID: 9086348
[TBL] [Abstract][Full Text] [Related]
8. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib in patients with metastatic renal cell carcinoma.
Motzer RJ; Rini BI; Bukowski RM; Curti BD; George DJ; Hudes GR; Redman BG; Margolin KA; Merchan JR; Wilding G; Ginsberg MS; Bacik J; Kim ST; Baum CM; Michaelson MD
JAMA; 2006 Jun; 295(21):2516-24. PubMed ID: 16757724
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib treatment of metastatic renal cell carcinoma in von Hippel-Lindau disease.
Tsimafeyeu I
J Cancer Res Ther; 2015; 11(4):920-2. PubMed ID: 26881543
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant sunitinib effectiveness in T4 renal clear cell carcinoma: a case report.
Ricciardulli S; Del Biondo D; Cicero C; Leo G; Zeccolini G; Celia A
Urologia; 2015; 82(2):109-13. PubMed ID: 25050998
[TBL] [Abstract][Full Text] [Related]
12. [A case of adrenal metastasectomy in renal cell carcinoma after neoadjuvant therapy with sunitinib].
Hamada A; Sunada T; Kato K; Sawada A; Kawanishi H; Okumura K
Hinyokika Kiyo; 2014 Feb; 60(2):79-82. PubMed ID: 24755818
[TBL] [Abstract][Full Text] [Related]
13. [Pre- surgical therapy with sunitinib for adrenal metastasis from renal cell carcinoma : a case report].
Inoue T; Murota T; Masuda T; Nishida T; Kawakita S; Kinoshita H; Matsuda T
Hinyokika Kiyo; 2013 Sep; 59(9):573-7. PubMed ID: 24113755
[TBL] [Abstract][Full Text] [Related]
14. Long-term response with sunitinib for metastatic renal cell carcinoma.
Ronnen EA; Kondagunta GV; Ginsberg MS; Russo P; Motzer RJ
Urology; 2006 Sep; 68(3):672.e19-20. PubMed ID: 16979716
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma with a huge solitary metastasis to the contralateral adrenal gland: a case report.
Utsumi T; Suzuki H; Nakamura K; Kim W; Kamijima S; Awa Y; Araki K; Nihei N; Naya Y; Ichikawa T
Int J Urol; 2008 Dec; 15(12):1077-9. PubMed ID: 19120516
[TBL] [Abstract][Full Text] [Related]
16. Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.
Michaelson MD; Iliopoulos O; McDermott DF; McGovern FJ; Harisinghani MG; Oliva E
N Engl J Med; 2008 May; 358(22):2389-96. PubMed ID: 18509125
[No Abstract] [Full Text] [Related]
17. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm.
Shuch B; Riggs SB; LaRochelle JC; Kabbinavar FF; Avakian R; Pantuck AJ; Patard JJ; Belldegrun AS
BJU Int; 2008 Sep; 102(6):692-6. PubMed ID: 18410444
[TBL] [Abstract][Full Text] [Related]
18. Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma.
Lane BR; Derweesh IH; Kim HL; O'Malley R; Klink J; Ercole CE; Palazzi KL; Thomas AA; Rini BI; Campbell SC
Urol Oncol; 2015 Mar; 33(3):112.e15-21. PubMed ID: 25532471
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function.
Maita S; Yuasa T; Tsuchiya N; Mitobe Y; Narita S; Horikawa Y; Hatake K; Fukui I; Kimura S; Maekawa T; Habuchi T
Int J Cancer; 2012 Feb; 130(3):677-84. PubMed ID: 21387300
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib.
Zimmermann K; Schmittel A; Steiner U; Asemissen AM; Knoedler M; Thiel E; Miller K; Keilholz U
Oncology; 2009; 76(5):350-4. PubMed ID: 19321976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]